Group (n = 6) | Heart (g) | Kidney (g) | Liver (g) | Spleen (g) |
---|
NC | 0.29 ± 0.03ab
| 0.55 ± 0.04a
| 3.25 ± 0.44ab
| 0.42 ± 0.09a
|
P407 | 0.31 ± 0.04b
| 0.61 ± 0.08a
| 4.66 ± 0.88c
| 0.87 ± 0.17b
|
ATV + P407 | 0.29 ± 0.02ab
| 0.55 ± 0.04a
| 3.57 ± 0.39b
| 0.44 ± 0.97a
|
RBBF + P407 | 0.26 ± 0.02a
| 0.51 ± 0.08a
| 2.94 ± 0.12a
| 0.38 ± 0.08a
|
SBBF + P407 | 0.26 ± 0.01a
| 0.54 ± 0.03a
| 3.25 ± 0.28ab
| 0.45 ± 0.06a
|
SBF + P407 | 0.28 ± 0.01ab
| 0.52 ± 0.05a
| 3.13 ± 0.24ab
| 0.38 ± 0.05a
|
- Values are means ± Standard deviations
- Values with different superscripts down the column differ significantly (p < 0.05)
-
NC Normal Control Rats, P407 Poloxamer 407 Induced Rats (500 mg/kg), ATV + P407 Atorvastatin (10 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), RBBF + P407 Root bark Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), SBBF + P407 Stem bark Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg), SBF + P407 Seed Biflavonoid Fraction (200 mg/kg) + P407 Induced Hyperlipidemic Rats (500 mg/kg)